Zkusit zdarma
CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc.

CBAY
Cena:
 
 
Valuace
70
Růst
8
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates

CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates

19:11 28-02-2024

CymaBay Therapeutics Inc. (CBAY) came out with a quarterly loss of $0.35 per share versus the Zacks ...

Why Gilead Sciences Is Buying CymaBay Therapeutics for $4.3 Billion

Why Gilead Sciences Is Buying CymaBay Therapeutics for $4.3 Billion

13:55 12-02-2024

Shares of CymaBay Therapeutics (CBAY) soared to an all-time high Monday after Gilead Sciences (GILD)...

Why is CymaBay (CBAY) Stock Up 25% Today?

Why is CymaBay (CBAY) Stock Up 25% Today?

11:09 12-02-2024

CymaBay (NASDAQ: CBAY ) stock is rising higher on Monday after the clinical-stage biopharmaceutical ...

Gilead to buy CymaBay Therapeutics for $4.3 billion

Gilead to buy CymaBay Therapeutics for $4.3 billion

9:33 12-02-2024

CymaBay Therapeutics Inc (NASDAQ: CBAY) opened more than 25% up this morning after Gilead Sciences I...

Drugmaker Gilead to acquire CymaBay for $4.3 bln

Drugmaker Gilead to acquire CymaBay for $4.3 bln

8:42 12-02-2024

Gilead Sciences on Monday said it will acquire CymaBay Therapeutics for $4.3 billion, to expand its ...

Gilead strikes deal to acquire CymaBay for $4.3 billion

Gilead strikes deal to acquire CymaBay for $4.3 billion

8:42 12-02-2024

Gilead Sciences Inc. GILD, -0.18% said Monday it has reached a deal to acquire CymaBay Therapeutics ...

CymaBay Therapeutics Inc. (CBAY) is on the Move, Here's Why the Trend Could be Sustainable

CymaBay Therapeutics Inc. (CBAY) is on the Move, Here's Why the Trend Could be Sustainable

10:34 25-10-2023

CymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a g...

Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today

Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today

18:16 23-10-2023

The leading drug candidate in the biotech's pipeline scored another win. Seladelpar's existing Break...

Why CymaBay Therapeutics Stock Is Sinking This Week

Why CymaBay Therapeutics Stock Is Sinking This Week

16:39 21-09-2023

CymaBay Therapeutics stock is continuing a slide that began last week. The pullback came on the heel...

CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference

CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference

8:00 15-09-2023

NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biop...

Why CymaBay Therapeutics Stock Triumphed Again on Tuesday

Why CymaBay Therapeutics Stock Triumphed Again on Tuesday

17:37 12-09-2023

The biotech upsized its planned share issue. It's now seeking to raise gross proceeds of $225 millio...

Why CymaBay Therapeutics Stock Popped Again Today

Why CymaBay Therapeutics Stock Popped Again Today

18:31 11-09-2023

The biotech is going to the well for more capital. It is seeking to raise $150 million in a share-an...

CymaBay: Positive Phase 3 Data And Competitive Advantage Established

CymaBay: Positive Phase 3 Data And Competitive Advantage Established

6:05 10-09-2023

Positive results achieved in phase 3 RESPONSE study, which used seladelpar for the treatment of pati...

CymaBay (CBAY) Stock Up on Positive Results From PBC Study

CymaBay (CBAY) Stock Up on Positive Results From PBC Study

14:17 08-09-2023

CymaBay (CBAY) reports encouraging data from the phase III study of seladelpar in PBC patients. Stoc...

Why CymaBay Therapeutics Stock Is Jumping Today

Why CymaBay Therapeutics Stock Is Jumping Today

11:59 08-09-2023

CymaBay announced positive results on Thursday for its treatment for a rare liver disease. The compa...

CymaBay Therapeutics stock jumps as rare liver disease treatment shows positive results

CymaBay Therapeutics stock jumps as rare liver disease treatment shows positive results

8:04 07-09-2023

Shares of CymaBay Therapeutics Inc. CBAY gained 23% premarket on Thursday after the company released...

close

GILEAD SCIENCES ANNOUNCES COMPLETION OF ACQUISITION OF CYMABAY

22-03-2024
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED THE COMPL...
Více zde

CYMABAY ANNOUNCES EUROPEAN MEDICINES AGENCY ACCEPTS FOR REVIEW THE MARKETING AUTHORIZATION APPLICATION FOR SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

04-03-2024
MAA VALIDATION FOLLOWS RECENT APPLICATIONS FOR SELADELPAR TO THE U.K. MHRA AND U.S. FDA MAA VALIDATI...
Více zde

CYMABAY REPORTS FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

28-02-2024
GILEAD SCIENCES, INC. HAS PROPOSED TO ACQUIRE CYMABAY FOR $32.50 PER SHARE IN CASH OR A TOTAL EQUITY...
Více zde

THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE PHASE 3 RESPONSE DATA OF CYMABAY'S SELADELPAR IN PRIMARY BILIARY CHOLANGITIS

21-02-2024
-  SELADELPAR DEMONSTRATED NORMALIZATION OF LIVER BIOMARKERS AND SIGNIFICANT REDUCTIONS ACROSS THRE...
Více zde

CYMABAY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

20-02-2024
NEWARK, CALIF., FEB. 20, 2024 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLINI...
Více zde

CYMABAY THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF CYMABAY THERAPEUTICS, INC. - CBAY

16-02-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER CYMABAY THERAPEUTICS, INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH GILEAD

12-02-2024
MILWAUKEE , FEB. 12, 2024 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING CYMABAY (NASDAQ: CBAY)  FOR PO...
Více zde

CBAY STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF CYMABAY THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

12-02-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

CYMABAY ANNOUNCES FDA ACCEPTANCE OF NDA AND PRIORITY REVIEW FOR SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

12-02-2024
-  FDA HAS GRANTED PRIORITY REVIEW WITH A TARGET PDUFA DATE OF AUGUST 14 - NEWARK, CALIF. , FEB. 12...
Více zde

GILEAD SCIENCES EXPANDS LIVER PORTFOLIO WITH ACQUISITION OF CYMABAY THERAPEUTICS

12-02-2024
FOSTER CITY, CALIF. & NEWARK, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) AND CYMA...
Více zde

CYMABAY THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTMENT CONFERENCES

31-01-2024
NEWARK, CALIF., JAN. 31, 2024 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-01-2024
NEWARK, CALIF., JAN. 16, 2024 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLINI...
Více zde

NEW PUBLISHED DATA DEMONSTRATES CORRELATION BETWEEN ITCH CYTOKINE INTERLEUKIN-31 REDUCTION AND PRURITIS IMPROVEMENT IN PRIMARY BILIARY CHOLANGITIS IN PHASE 3 POST-HOC ANALYSIS OF CYMABAY'S SELADELPAR

03-01-2024
-- FIRST CLINICAL TRIAL IN PBC TO SHOW COORDINATE REDUCTIONS OF IL-31, BILE ACIDS AND PRURITUS -- NE...
Více zde

CYMABAY THERAPEUTICS TO PRESENT AT THE 42ND ANNUAL JP MORGAN HEALTHCARE CONFERENCE 2024

02-01-2024
NEWARK, CALIF., JAN. 02, 2024 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

18-12-2023
NEWARK, CALIF., DEC. 18, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLINI...
Více zde

CYMABAY SUBMITS NEW DRUG APPLICATION TO FDA FOR SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

15-12-2023
- NDA IS SUPPORTED BY DATA EVALUATING SELADELPAR EFFICACY AND SAFETY IN OVER 500 PATIENTS -  - SELA...
Více zde

CYMABAY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

17-11-2023
NEWARK, CALIF., NOV. 17, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLINI...
Více zde

CYMABAY ANNOUNCES AN ORAL PRESENTATION OF SELADELPAR PHASE 3 PIVOTAL RESULTS IN PRIMARY BILIARY CHOLANGITIS AT THE LATE BREAKER SESSION OF THE LIVER MEETING®

13-11-2023
61.7% OF PATIENTS ON SELADELPAR 10 MG ACHIEVED THE PRIMARY COMPOSITE ENDPOINT VS. 20.0% OF PATIENTS ...
Více zde

CYMABAY REPORTS THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07-11-2023
ANNOUNCED TOP-LINE RESULTS FROM RESPONSE PHASE 3 STUDY IN PBC WHERE SELADELPAR MET THE PRIMARY AND T...
Více zde

CYMABAY THERAPEUTICS TO PRESENT AT UPCOMING INVESTMENT CONFERENCES

06-11-2023
NEWARK, CALIF., NOV. 06, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY ANNOUNCES PUBLICATION OF TWO-YEAR SAFETY AND EFFICACY RESULTS OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

01-11-2023
NEWARK, CALIF., NOV. 01, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY THERAPEUTICS TO REPORT THIRD QUARTER OF 2023 FINANCIAL RESULTS ON TUESDAY, NOVEMBER 7, 2023

31-10-2023
NEWARK, CALIF., OCT. 31, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY PRESENTS RESULTS ON THE POTENTIAL OF SELADELPAR IN TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AT ACG 2023

23-10-2023
CHOLESTATIC PRURITUS EXPERT LEADS PLENARY DISCUSSION OF CORRELATED DECREASES IN SERUM IL-31 LEVELS A...
Více zde

SELADELPAR GRANTED REVISED BREAKTHROUGH THERAPY DESIGNATION FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS INCLUDING PRURITUS IN PATIENTS WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS

23-10-2023
NEWARK, CALIF., OCT. 23, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOPH...
Více zde

CYMABAY'S RESPONSE PHASE 3 DATA EVALUATING SELADELPAR FOR PRIMARY BILIARY CHOLANGITIS TO BE FEATURED IN AN ORAL LATE-BREAKING PRESENTATION AT THE LIVER MEETING® 2023

18-10-2023
RESULTS FROM THE RESPONSE REGISTRATIONAL STUDY TO BE HIGHLIGHTED IN ORAL PRESENTATION ON MONDAY, NOV...
Více zde

CYMABAY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

16-10-2023
NEWARK, CALIF., OCT. 16, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLINI...
Více zde

CYMABAY INITIATES AFFIRM, A PHASE 3B/4 STUDY EVALUATING THE EFFECT OF SELADELPAR ON CLINICAL OUTCOMES IN PATIENTS WITH CIRRHOSIS DUE TO PRIMARY BILIARY CHOLANGITIS

21-09-2023
AFFIRM IS A UNIQUE EVENT-DRIVEN, FIXED-DURATION DESIGN INTENDED TO REDUCE THE CHALLENGES FOR PATIENT...
Více zde

CYMABAY THERAPEUTICS TO PRESENT AT THE CANTOR GLOBAL HEALTHCARE CONFERENCE

15-09-2023
NEWARK, CALIF., SEPT. 15, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A BIOP...
Více zde

CYMABAY ANNOUNCES CLOSING OF UPSIZED $258.7 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS, INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

14-09-2023
NEWARK, CALIF., SEPT. 14, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLIN...
Více zde

CYMABAY ANNOUNCES PRICING OF UPSIZED $225 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

11-09-2023
NEWARK, CALIF., SEPT. 11, 2023 (GLOBE NEWSWIRE) -- CYMABAY THERAPEUTICS, INC. (NASDAQ: CBAY), A CLIN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-03-20 00:00:008-KStáhnout
2024-03-19 23:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-02-12 00:00:008-KStáhnout
2024-02-11 23:00:008-KStáhnout
2024-01-26 00:00:008-KStáhnout
2024-01-25 23:00:008-KStáhnout
2023-12-21 00:00:008-KStáhnout
2023-12-20 23:00:008-KStáhnout
2023-12-13 00:00:008-KStáhnout
2023-12-12 23:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-12 01:00:008-KStáhnout
2023-09-12 00:00:008-KStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 00:00:008-KStáhnout
2023-03-23 00:00:0010-KStáhnout
2023-03-22 23:00:0010-KStáhnout
2023-03-16 00:00:008-KStáhnout
2023-03-15 23:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-01-25 00:00:008-KStáhnout
2023-01-24 23:00:008-KStáhnout
2023-01-23 00:00:008-KStáhnout
2023-01-22 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-11-01 00:00:008-KStáhnout
2022-10-31 23:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-14 01:00:008-KStáhnout
2022-06-14 00:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-17 00:00:008-KStáhnout
2022-03-17 00:00:0010-KStáhnout
2022-03-16 23:00:008-KStáhnout
2022-03-16 23:00:0010-KStáhnout
2021-11-18 00:00:008-KStáhnout
2021-11-17 23:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-08-02 01:00:008-KStáhnout
2021-08-02 00:00:008-KStáhnout
2021-06-14 01:00:008-KStáhnout
2021-06-14 00:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-04-05 01:00:008-KStáhnout
2021-04-05 00:00:008-KStáhnout
2021-03-25 00:00:0010-KStáhnout
2021-03-24 23:00:0010-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-06-26 01:00:008-KStáhnout
2020-06-26 00:00:008-KStáhnout
2020-05-11 01:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:008-KStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2020-03-12 00:00:008-KStáhnout
2020-03-11 23:00:008-KStáhnout
2020-01-29 00:00:008-KStáhnout
2020-01-28 23:00:008-KStáhnout
2019-12-19 00:00:008-KStáhnout
2019-12-18 23:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-09-17 01:00:008-KStáhnout
2019-09-17 00:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 00:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-03-06 00:00:008-KStáhnout
2019-03-05 23:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2019-02-04 00:00:008-KStáhnout
2019-02-03 23:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-10-30 00:00:008-KStáhnout
2018-10-29 23:00:008-KStáhnout
2018-08-09 01:00:0010-QStáhnout
2018-08-09 00:00:0010-QStáhnout
2018-06-26 01:00:008-KStáhnout
2018-06-26 00:00:008-KStáhnout
2018-06-07 01:00:008-KStáhnout
2018-06-07 00:00:008-KStáhnout
2018-05-08 01:00:0010-QStáhnout
2018-05-08 00:00:0010-QStáhnout
2018-04-20 01:00:008-KStáhnout
2018-04-20 00:00:008-KStáhnout
2018-03-15 00:00:0010-KStáhnout
2018-03-14 23:00:0010-KStáhnout
2018-01-30 00:00:008-KStáhnout
2018-01-29 23:00:008-KStáhnout
2018-01-12 00:00:008-KStáhnout
2018-01-11 23:00:008-KStáhnout
2017-11-08 00:00:0010-QStáhnout
2017-11-07 23:00:0010-QStáhnout
2017-11-01 00:00:008-KStáhnout
2017-10-31 23:00:008-KStáhnout
2017-08-10 01:00:0010-QStáhnout
2017-08-10 00:00:0010-QStáhnout
2017-07-19 01:00:008-KStáhnout
2017-07-19 00:00:008-KStáhnout
2017-06-05 01:00:008-KStáhnout
2017-06-05 00:00:008-KStáhnout
2017-05-11 01:00:0010-QStáhnout
2017-05-11 00:00:0010-QStáhnout
2017-05-03 01:00:008-KStáhnout
2017-05-03 00:00:008-KStáhnout
2017-03-29 01:00:008-KStáhnout
2017-03-29 00:00:008-KStáhnout
2017-03-23 00:00:0010-KStáhnout
2017-03-22 23:00:0010-KStáhnout
2017-02-03 00:00:008-KStáhnout
2017-02-02 23:00:008-KStáhnout
2017-01-24 00:00:008-KStáhnout
2017-01-23 23:00:008-KStáhnout
2017-01-05 00:00:008-KStáhnout
2017-01-04 23:00:008-KStáhnout
2016-12-08 00:00:008-KStáhnout
2016-12-07 23:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-10-07 01:00:008-KStáhnout
2016-10-07 00:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-06-06 01:00:008-KStáhnout
2016-06-06 00:00:008-KStáhnout
2016-05-24 01:00:008-KStáhnout
2016-05-24 00:00:008-KStáhnout
2016-05-11 01:00:0010-QStáhnout
2016-05-11 00:00:0010-QStáhnout
2016-03-29 01:00:0010-KStáhnout
2016-03-29 00:00:0010-KStáhnout
2016-03-28 01:00:008-KStáhnout
2016-03-28 00:00:008-KStáhnout
2016-03-22 00:00:008-KStáhnout
2016-03-21 23:00:008-KStáhnout
2016-01-29 00:00:008-KStáhnout
2016-01-28 23:00:008-KStáhnout
2016-01-20 00:00:008-KStáhnout
2016-01-19 23:00:008-KStáhnout
2015-11-12 00:00:008-KStáhnout
2015-11-12 00:00:0010-QStáhnout
2015-11-11 23:00:008-KStáhnout
2015-11-11 23:00:0010-QStáhnout
2015-10-08 01:00:008-KStáhnout
2015-10-08 00:00:008-KStáhnout
2015-09-09 01:00:008-KStáhnout
2015-09-09 00:00:008-KStáhnout
2015-08-11 01:00:0010-QStáhnout
2015-08-11 00:00:0010-QStáhnout
2015-08-10 01:00:008-KStáhnout
2015-08-10 00:00:008-KStáhnout
2015-07-15 01:00:008-KStáhnout
2015-07-15 00:00:008-KStáhnout
2015-06-03 01:00:008-KStáhnout
2015-06-03 00:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-04-21 01:00:008-KStáhnout
2015-04-21 00:00:008-KStáhnout
2015-03-24 00:00:008-KStáhnout
2015-03-23 23:00:008-KStáhnout
2015-03-23 00:00:0010-KStáhnout
2015-03-22 23:00:0010-KStáhnout
2015-03-03 00:00:008-KStáhnout
2015-03-02 23:00:008-KStáhnout
2015-03-02 00:00:008-KStáhnout
2015-03-01 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2014-12-29 00:00:008-KStáhnout
2014-12-28 23:00:008-KStáhnout
2014-11-14 00:00:0010-QStáhnout
2014-11-13 23:00:0010-QStáhnout
2014-11-12 00:00:008-KStáhnout
2014-11-11 23:00:008-KStáhnout
2014-08-14 01:00:0010-QStáhnout
2014-08-14 00:00:0010-QStáhnout
2014-06-06 01:00:008-KStáhnout
2014-06-06 00:00:008-KStáhnout
2014-05-15 01:00:0010-QStáhnout
2014-05-15 00:00:0010-QStáhnout
2014-03-31 01:00:0010-KStáhnout
2014-03-31 00:00:0010-KStáhnout
2014-02-21 00:00:008-KStáhnout
2014-02-20 23:00:008-KStáhnout
2014-01-13 00:00:008-KStáhnout
2014-01-12 23:00:008-KStáhnout
2014-01-08 00:00:008-KStáhnout
2014-01-07 23:00:008-KStáhnout
2013-12-27 00:00:008-KStáhnout
2013-12-26 23:00:008-KStáhnout
2013-12-12 00:00:008-KStáhnout
2013-12-11 23:00:008-KStáhnout
2013-12-11 00:00:008-KStáhnout
2013-12-10 23:00:008-KStáhnout
2013-11-29 00:00:008-KStáhnout
2013-11-28 23:00:008-KStáhnout
2013-11-25 00:00:0010-QStáhnout
2013-11-24 23:00:0010-QStáhnout
2013-11-13 00:00:008-KStáhnout
2013-11-12 23:00:008-KStáhnout
2013-11-05 00:00:008-KStáhnout
2013-11-04 23:00:008-KStáhnout
2013-11-01 00:00:008-KStáhnout
2013-10-31 23:00:008-KStáhnout
preloader